Association Between Adverse Effects Under Azathioprine Therapy and Inosine Triphosphate Pyrophosphatase Activity in Patients With Chronic Inflammatory Bowel Disease
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association Between Adverse Effects Under Azathioprine Therapy and Inosine Triphosphate Pyrophosphatase Activity in Patients With Chronic Inflammatory Bowel Disease
Authors
Keywords
-
Journal
THERAPEUTIC DRUG MONITORING
Volume 33, Issue 3, Pages 321-328
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-05-04
DOI
10.1097/ftd.0b013e31821a7c34
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thiopurines: Factors influencing toxicity and response
- (2010) Alan Kambiz Fotoohi et al. BIOCHEMICAL PHARMACOLOGY
- On Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease; Pharmacology, Pharmacogenomics, Drug Intolerance and Clinical Relevance
- (2010) Dirk Van Asseldonk et al. CURRENT DRUG METABOLISM
- Genetic Variations in the HGPRT, ITPA, IMPDH1, IMPDH2, and GMPS Genes in Japanese Individuals
- (2010) Mutsumi Kudo et al. Drug Metabolism and Pharmacokinetics
- Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?
- (2010) Jenny E Higgs et al. PHARMACOGENOMICS
- Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease
- (2010) Xian-Wen Dong WORLD JOURNAL OF GASTROENTEROLOGY
- The Increasing Complexity of Mercaptopurine Pharmacogenomics
- (2009) S Marsh et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics of Thiopurines in Inflammatory Bowel Disease
- (2009) L. Derijks et al. CURRENT PHARMACEUTICAL DESIGN
- TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients
- (2009) Mateusz Kurzawski et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Association between inosine triphosphate pyrophosphohydrolase deficiency and azathioprine-related adverse drug reactions in the Chinese kidney transplant recipients
- (2009) Hui Xiong et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatment
- (2009) Kan Uchiyama et al. JOURNAL OF GASTROENTEROLOGY
- Individualization of thiopurine therapy: thiopurineS-methyltransferase and beyond
- (2009) Natasa Karas-Kuzelicki et al. PHARMACOGENOMICS
- Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease
- (2008) A. ANSARI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine
- (2008) Ahmed F. Hawwa et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia
- (2008) G Stocco et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn”
- (2008) J Hoffmann et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More